Resmed's divestiture hands off the EHR software business MatrixCare to Frazier Healthcare Partners, a private equity firm focused exclusively on healthcare. Resmed CEO Mick Farrell said the company views Frazier as a suitable steward for MatrixCare's team and solutions. The transaction, expected to close in the third quarter, includes MatrixCare's related software offerings sold under the MatrixCare brand, including Healthcare First, Citus, and home health and hospice solutions. The companies did not disclose the terms of the deal.
This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.
(END) Dow Jones Newswires
July 07, 2026 17:27 ET (21:27 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.